Related Experiment Video
Updated: Apr 22, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Structure activity relationship of Aristolochic acid analogues: Inhibitory effect on human and rat gonadal
Weijian Zhu1, Zhuoqi Chen2, Shaowei Wang2
1Department of Obstetrics and Gynecology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Central Laboratory, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Abstract:
Aristolochia species have been used in traditional Chinese medicine for over 1500 years to treat gynecological disorders. Recent pharmacological efforts focus on developing safer aristolochic acid derivatives (AAs) to retain therapeutic efficacy while minimizing toxicity. Human 3β-hydroxysteroid dehydrogenase 2 (h3β-HSD2) catalyzes the formation of precursors for sex hormones and corticosteroids, which play critical role in endocrine disorders such as polycystic ovary syndrome (PCOS) and Cushing's syndrome. This study aimed to evaluate AAs for their inhibitory effects on h3β-HSD2 and compared it with rat testicular 3β-HSD1. The inhibitory strength on h3β-HSD2 was AAB (IC50, 18.31 μM) > aristololactam I (28.52 μM) > AAC (39.73 μM) > AAD (164.76 μM). The inhibitory strength on rat 3β-HSD1 was AAB (IC50, 17.52 μM) > AAI (31.37 μM) > AAC (37.32 μM) > aristolone (89.66 μM). Docking showed that all chemicals bind to NAD+-binding site with the mix mode. AAs dose-dependently inhibited P4 synthesis in KGN cells, and ALI showed no cytotoxicity even at 100 μM. Overall, this study identifies AAs as potent inhibitors of h3β-HSD2 and r3β-HSD1, enzymes implicated in the pathophysiology of PCOS and Cushing's syndrome. Safe AAs-based therapeutics for endocrine disorders may be achievable.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

